Heme, as an essential component of hemoproteins, is a prosthetic co-factor found in many cells, which is essential for physiologically vital
oxygen transport. However, extracellular or circulatory
heme is cytotoxic and triggers
inflammation. Although the proinflammatory role of
heme has been reported to be associated with
Toll-like receptor 4 (TLR4) signaling, the exact mechanism remains unknown. Here, we show that
heme promotes TLR4 signaling and
inflammation via directly physically interacting with TLR4 and its adaptor
protein myeloid differentiation
protein 2 (MD2). Genetic loss of MD2 ameliorates
heme-induced
inflammation and inflammatory
cytokine production in the spleen of MD2 knockout (MD2-/-) mice. Using mouse macrophage RAW 264.7 cell line, we show that
heme induces TLR4 dimerization and MD2/TLR4/MyD88 activation by physically interacting with TLR4 and MD2 in vitro. Genetic loss of MD2 inhibits
heme-induced
inflammation and MAPK/NF-κB pathway in mouse primary macrophages extracted from MD2-/- mice. Furthermore, pharmacological inhibition of MD2 by L6H9 ameliorates
heme-induced
inflammation in macrophages. These findings demonstrate that
heme causes
inflammation by directly binding to MD2/TLR4 complex, leading to activation of TLR4/MAPK/NF-κB signaling pathway and production of downstream effectors of
inflammation.